DWI与DCE-MRI评估乳腺癌新辅助化疗病理反应的诊断效能:一项荟萃分析
该荟萃分析纳入41篇文献,比较DWI与DCE-MRI预测乳腺癌新辅助化疗病理反应的诊断效能。DCE-MRI汇总敏感度0.75、特异度0.79,DWI汇总敏感度0.77、特异度0.75,两者敏感度(P=0.598)与特异度(P=0.218)无显著差异。DWI可能成为DCE-MRI的潜在替代方法,但需谨慎应用。
要点
- DWI与DCE-MRI预测乳腺癌新辅助化疗病理反应效能相当,无显著差异。
- DCE-MRI汇总敏感度0.75、特异度0.79;DWI汇总敏感度0.77、特异度0.75。
- 磁场强度与检查时间对异质性有显著影响,阅片报告需结合设备与时机。
核心结论
- DWI在预测乳腺癌新辅助化疗病理反应方面与DCE-MRI诊断效能无显著差异,可能作为潜在替代方法。
- 鉴于并非所有研究在同一患者中直接比较两种方法且存在异质性,应用结果时需谨慎。
研究设计与样本
- 系统检索PubMed、EMBASE、Cochrane Library和Web of Science自建库至2020年12月,纳入41篇文献。
- DCE-MRI相关27项研究共2107例患者,DWI相关23项研究共1321例患者。
- 采用QUADAS-2工具评估方法学质量,提取数据构建2×2表,使用STATA 12.0进行数据合并、异质性检验、荟萃回归及亚组分析。
诊断标准与关键数值
- DCE-MRI预测乳腺癌新辅助化疗病理反应的汇总敏感度为0.75、特异度为0.79。
- DWI预测乳腺癌新辅助化疗病理反应的汇总敏感度为0.77、特异度为0.75。
- DCE-MRI与DWI的敏感度差异无统计学意义(P=0.598),特异度差异无统计学意义(P=0.218)。
- 荟萃回归分析显示磁场强度和检查时间对异质性有显著影响。
临床应用与阅片要点
- DWI可作为DCE-MRI的潜在替代或补充序列用于预测乳腺癌新辅助化疗病理反应。
- 判读时需关注磁场强度与检查时间对诊断效能的影响,结合具体设备与扫描时机解释结果。
- 报告时应注明所用序列(DWI或DCE-MRI)及其汇总诊断效能,避免过度解读单一指标。
局限性
- 并非所有纳入研究在同一患者中直接比较DWI与DCE-MRI的诊断效能。
- 纳入研究存在异质性,磁场强度和检查时间对异质性有显著影响。
- 应用结果时需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate and compare the diagnostic performance of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in predicting the pathological response of breast cancer to neoadjuvant chemotherapy (NAC).
METHODS: We searched PubMed, EMBASE, Cochrane Library, and Web of Science systematically to identify relevant studies from inception to December 2020. The Quality Assessment of Diagnostic Accuracy Studies 2 tool was used to assess the methodological quality of the included studies. We extracted sufficient data to construct 2 × 2 tables and then used STATA 12.0 to perform data pooling, heterogeneity testing, meta-regression analysis and subgroup analysis.
RESULTS: A total of 41 articles were enrolled in this study, including 27 studies (2107 patients) on DCE-MRI and 23 studies (1321 patients) on DWI. The pooled sensitivity and specificity of DCE-MRI were 0.75 and 0.79, and the pooled sensitivity and specificity of DWI were 0.77 and 0.75. There was no significant difference in sensitivity (P = 0.598) and specificity (P = 0.218) between DCE-MRI and DWI. And meta-regression analysis showed that both magnetic field strength and the time of examination had significant effects on heterogeneity.
CONCLUSIONS: DWI might be a potential substitute for DCE-MRI in predicting the pathological response of breast cancer to NAC as there was no significant difference in the diagnostic performance between the two. However, considering that not all included studies directly compared the diagnostic performance of DWI and DCE-MRI in the same patients and the heterogeneity of the included studies, caution should be exercised in applying our results.
引用
- Li Z, Li J, Lu X, et al. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis. Eur J Radiol. 2021. PMID: 34492627. doi:10.1016/j.ejrad.2021.109931
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。